本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fennec Pharmaceuticals Inc.

8.80
+0.26003.04%
盘后8.800.00000.00%15:12 EDT
成交量:8.02万
成交额:69.64万
市值:2.43亿
市盈率:-16.72
高:8.88
开:8.57
低:8.38
收:8.54
数据加载中...
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/04

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/07

重要事件披露

Form 8-K - Current report
2025/02/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]